Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:1097-1103
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shindler, D. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shindler, D. M.

CLINICAL STUDY

Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

Daniel M. Shindler, MD, FACC*, Sebastian T. Palmeri, MD, FACC*, Tracy A. Antonelli, MPH{dagger}, Lynn A. Sleeper, ScD{dagger}, Jean Boland, MD{ddagger}, Thomas P. Cocke, MD, FACC§, Judith S. Hochman, MD, FACC|| for the SHOCK Investigators

* UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
{dagger} New England Research Institutes, Watertown, Massachusetts, USA
{ddagger} Centre Hospitalier de la Citadelle, Liège, Belgium
§ Mt. Sinai Medical Center, New York, New York, USA
|| St. Luke’s–Roosevelt Hospital, New York, New York, USA

Manuscript received February 16, 2000; revised manuscript received June 2, 2000, accepted June 7, 2000.

Reprint requests and correspondence: Dr. Daniel M. Shindler, 1 Gloucester Court, East Brunswick, New Jersey 08816
shindler{at}umdnj.edu

OBJECTIVES

We sought to examine the role of diabetes mellitus in cardiogenic shock (CS) complicating acute myocardial infarction (AMI) in the SHOCK Trial Registry.

BACKGROUND

The characteristics, outcomes and optimal treatment of diabetic patients with CS complicating AMI have not been well described.

METHODS

Baseline characteristics, clinical and hemodynamic measures, treatment variables, shock etiologies and comorbid conditions were compared for 379 diabetic and 784 nondiabetic patients. Logistic regression was used to examine the association between diabetes and in-hospital mortality, after adjustment for baseline differences.

RESULTS

Diabetics were less likely than nondiabetics to undergo thrombolysis (28% vs. 37%; p = 0.002) or attempted revascularization (40% vs. 49%; p = 0.008). The survival benefit for diabetics selected for percutaneous or surgical revascularization (55% vs. 19% without revascularization) was similar to that for nondiabetics (59% vs. 25%). Overall unadjusted in-hospital mortality was significantly higher for diabetics (67% vs. 58%; p = 0.007), but diabetes was only a borderline predictor of mortality after adjustment for baseline and treatment differences (odds ratio for death, 1.36; 95% confidence interval, 1.00 to 1.84; p = 0.051).

CONCLUSIONS

Diabetics with CS complicating AMI have a higher-risk profile at baseline, but after adjustment, diabetics have an in-hospital survival rate that is only marginally lower than that of nondiabetics. Diabetics who undergo revascularization derive a survival benefit similar to that of nondiabetics.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  BARI = Bypass Angioplasty Revascularization Investigation
  BUN = blood urea nitrogen
  CK(-MB) = creatine kinase (-MB)
  CS = cardiogenic shock
  GUSTO-I = Global Utilization of Streptokinase and TPA (alteplase) for Occluded coronary arteries (trial)
  LV = left ventricular, left ventricle
  MR = mitral regurgitation
  RV = right ventricular
  SHOCK = SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? (trial)




This article has been cited by other articles:


Home page
Circ Heart FailHome page
D. Aronson, A. Musallam, J. Lessick, S. Dabbah, S. Carasso, H. Hammerman, S. Reisner, Y. Agmon, and D. Mutlak
Impact of Diastolic Dysfunction on the Development of Heart Failure in Diabetic Patients After Acute Myocardial Infarction
Circ Heart Fail, January 1, 2010; 3(1): 125 - 131.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Ohno, S. Takamoto, and N. Motomura
Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective
Ann. Thorac. Surg., February 1, 2008; 85(2): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
C. P Gale, C. Kashinath, and P. Brooksby
The association between hyperglycaemia and elevated troponin levels on mortality in acute coronary syndromes
Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 80 - 83.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
M.G. Lindholm, S. Boesgaard, C. Torp-Pedersen, L. Kober, and on behalf of the TRACE registry study group
Diabetes mellitus and cardiogenic shock in acute myocardial infarction
Eur J Heart Fail, August 1, 2005; 7(5): 834 - 839.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. F. Luscher, M. A. Creager, J. A. Beckman, and F. Cosentino
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II
Circulation, September 30, 2003; 108(13): 1655 - 1661.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. V. Tedesco, R. S. Wright, B. A. Williams, S. L. Kopecky, D. L. Dvorak, G. S. Reeder, W. L. Miller, and Mayo Coronary Care Unit Group
Effect of Diabetes on the Mortality Risk of Cardiogenic Shock in a Community-Based Population
Mayo Clin. Proc., May 1, 2003; 78(5): 561 - 566.
[Abstract] [PDF]


Home page
JAMAHome page
J. A. Beckman, M. A. Creager, and P. Libby
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
JAMA, May 15, 2002; 287(19): 2570 - 2581.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement